©The Author(s) 2025.
World J Transplant. Dec 18, 2025; 15(4): 106380
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.106380
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.106380
Table 4 Operating procedures before, during, and after keratoplasty, n (%)
| Procedure | n = 99 |
| Before keratoplasty | 69 (69.7) |
| Periosteal graft | 58 (58.6) |
| Amniotic membrane transplantation | 8 (8.1) |
| Intracameral injection of antifungal | 2 (2.0) |
| Conjunctival flap | 1 (1.0) |
| During keratoplasty | 41 (41.4) |
| ECCE | 29 (29.3) |
| ECCE + IOL | 12 (12.1) |
| After keratoplasty | 22 (22.2) |
| Phacoemulsification + IOL | 8 (8.1) |
| Micropulse | 4 (4.0) |
| Re-keratoplasty | 3 (3.0) |
| Glaucoma implant surgery | 3 (3.0) |
| Re-keratoplasty + ECCE IOL | 1 (1.0) |
| Buccal mucosa graft | 1 (1.0) |
| ECCE IOL | 1 (1.0) |
| Amniotic membrane transplant | 1 (1.0) |
- Citation: Edwar L, Budiman D, Sitompul R, Susiyanti M, Nora RLD, Aziza Y, Tuasikal RM, Badruddin GH. Clinical characteristics and outcomes of keratoplasty in moderate to severe infective corneal ulcers. World J Transplant 2025; 15(4): 106380
- URL: https://www.wjgnet.com/2220-3230/full/v15/i4/106380.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i4.106380